What Is Ductal Carcinoma In Situ (DCIS)? Symptoms, Diagnosis, and Treatment

Author : Nazma Khatoon | Published On : 30 Jul 2026

Ductal Carcinoma In Situ (DCIS) is an early form of breast cancer that starts in the milk ducts and remains confined within them. Since the abnormal cells have not spread into the surrounding breast tissue, DCIS is classified as Stage 0 breast cancer.

Although DCIS is considered non-invasive, it should not be ignored. Without appropriate treatment, some cases may progress to invasive breast cancer over time. Detecting DCIS early allows doctors to treat the condition before it spreads.

Learning about the early signs and symptoms of breast cancer can also help you recognize when a medical evaluation may be necessary.

What Is Ductal Carcinoma In Situ (DCIS)?

DCIS develops in the lining of the milk ducts, where abnormal cells remain contained within the ducts and do not invade nearby breast tissue.

The term "in situ" means "in its original place." It indicates that the abnormal cells have not broken through the duct wall or spread into surrounding tissues.

Because it is confined to the ducts, DCIS represents the earliest stage of breast cancer. Even though it is non-invasive, treatment is generally recommended to lower the risk of future progression.

Why Is DCIS Called Stage 0 Breast Cancer?

Breast cancer staging is based on how far cancer cells have spread.

In DCIS, the abnormal cells remain inside the milk ducts without invading nearby breast tissue, lymph nodes, or other parts of the body. This limited involvement is why it is classified as Stage 0.

If the abnormal cells grow beyond the ducts and invade surrounding tissue, the condition becomes invasive breast cancer.

Symptoms of DCIS

Most people diagnosed with DCIS do not experience noticeable symptoms. The condition is often detected during a routine screening mammogram before physical changes develop.

In some cases, symptoms may include:

A small breast lump.
Bloody or clear nipple discharge.
Changes in the nipple or nearby breast skin.

These symptoms are not specific to DCIS and can also occur in several non-cancerous breast conditions. Any new breast change should be assessed by a healthcare professional.

Risk Factors for DCIS

There is no single known cause of DCIS, but certain factors may increase the likelihood of developing it.

Increasing age.
Family history of breast cancer.
Inherited gene mutations such as BRCA1 or BRCA2.
Personal history of certain breast conditions.
Previous radiation therapy to the chest.
Long-term exposure to female hormones over a lifetime.

Having one or more risk factors does not mean that a person will definitely develop DCIS. Likewise, many people diagnosed with DCIS have no identifiable risk factors.

How Is DCIS Diagnosed?

DCIS is most commonly detected during a screening mammogram. Tiny calcium deposits called microcalcifications may appear on the images and prompt additional evaluation.

Further investigations may include:

Diagnostic mammography.
Breast ultrasound when clinically appropriate.
Breast MRI in selected cases.
Core needle biopsy to obtain a tissue sample.

The biopsy sample is examined by a pathologist to confirm the diagnosis. The pathology report also provides important information such as the grade of DCIS and hormone receptor status, which help guide treatment decisions.

Understanding the Pathology Report

A pathology report contains detailed information beyond the diagnosis. These findings help doctors select the most appropriate treatment plan.

The report may include:

Size of the DCIS.
Grade of the abnormal cells.
Surgical margin status.
Estrogen receptor (ER) and progesterone receptor (PR) status.
Presence or absence of comedo necrosis.

Each of these factors contributes to developing an individualized treatment strategy.

DCIS vs. Invasive Breast Cancer

Although both conditions involve abnormal breast cells, the key difference is whether the cells have spread beyond the milk ducts.

Ductal Carcinoma In Situ (DCIS)Invasive Breast CancerClassified as Stage 0 breast cancer.Usually classified as Stage I or higher.Confined to the milk ducts.Has spread into surrounding breast tissue.Does not spread to other parts of the body.May spread to lymph nodes or distant organs.Treatment aims to prevent progression.Treatment focuses on controlling invasive disease.

Understanding the Grade of DCIS

The grade describes how abnormal the cells appear under a microscope. It is different from the stage of cancer.

Low Grade: Cells resemble normal breast cells and generally grow slowly.
Intermediate Grade: Cells have characteristics between low and high grade.
High Grade: Cells appear more abnormal and may grow more rapidly.

The grade helps estimate the biological behavior of DCIS and supports treatment planning.

What Is Comedo Necrosis?

Comedo necrosis refers to an area of dead cells found inside the affected milk duct. It is a pathological finding that may be included in your biopsy report.

Its presence provides additional information about the disease. However, treatment decisions are based on multiple factors, including lesion size, grade, surgical margins, hormone receptor status, and the patient's overall health.

Treatment Options for DCIS

Treatment is individualized based on the characteristics of the disease and the patient's overall condition. The primary goal is to remove the abnormal cells and reduce the risk of recurrence.

Common treatment options include:

Breast-conserving surgery (lumpectomy).
Mastectomy when a larger portion of the breast is affected or in selected clinical situations.
Radiation therapy after lumpectomy for many patients.
Hormone therapy for hormone receptor-positive DCIS.

If surgery is recommended, understanding the available breast cancer surgery options can help you discuss the benefits and limitations of each approach with your surgeon.

Chemotherapy is generally not required for DCIS because the abnormal cells have not invaded the surrounding breast tissue.

Can DCIS Become Invasive?

Some untreated cases of DCIS may eventually progress to invasive breast cancer. Currently, it is not possible to accurately predict which cases will become invasive. For this reason, treatment is usually recommended once the diagnosis has been confirmed.

Regular follow-up after treatment is equally important to monitor for any new breast changes.

Recovery and Follow-Up Care

Following treatment, your doctor will recommend regular follow-up visits and routine mammograms. The frequency of follow-up depends on the treatment received and your overall health.

Maintaining a healthy lifestyle, staying aware of breast changes, and attending scheduled follow-up appointments are important parts of long-term care. Ongoing advances in breast cancer surgery techniques continue to improve treatment outcomes and patient care.

Frequently Asked Questions (FAQs)

Is DCIS considered breast cancer?

Yes. DCIS is classified as Stage 0 breast cancer because the abnormal cells remain confined within the milk ducts and have not invaded nearby breast tissue.

Can DCIS spread to other organs?

No. DCIS itself does not spread to distant organs. It remains within the milk ducts unless it progresses to invasive breast cancer.

Will everyone with DCIS need a mastectomy?

No. Many patients are successfully treated with breast-conserving surgery. The most suitable procedure depends on the size, location, and extent of the DCIS.

Does every patient with DCIS need radiation therapy?

Radiation therapy is commonly recommended after lumpectomy, but the decision is based on individual clinical factors and should be discussed with the treating doctor.

Conclusion

Ductal Carcinoma In Situ (DCIS) is the earliest stage of breast cancer and remains confined to the milk ducts. Although it is non-invasive, timely diagnosis and appropriate treatment are essential to reduce the risk of future invasive disease. Understanding your pathology report, available treatment options, and recommended follow-up care can help you make informed decisions together with your healthcare team.